Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam☆
To access this article, please choose from the options below
☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.
PII: S0168-8278(09)00379-1
doi:10.1016/j.jhep.2009.05.027
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
Refers to article:
- HCV reinfection studies and the door to vaccine development , 17 July 2009
